BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 34999727)

  • 1. Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report.
    Loschi M; Roux C; Sudaka I; Ferrero-Vacher C; Marceau-Renaut A; Duployez N; Passeron T; Cluzeau T
    Bone Marrow Transplant; 2022 Feb; 57(2):315-318. PubMed ID: 34999727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience.
    Diarra A; Duployez N; Fournier E; Preudhomme C; Coiteux V; Magro L; Quesnel B; Heiblig M; Sujobert P; Barraco F; Balsat M; Scanvion Q; Hachulla E; Launay D; Yakoub-Agha I; Terriou L
    Blood Adv; 2022 Feb; 6(3):998-1003. PubMed ID: 34714914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two cases of VEXAS syndrome].
    Gunnarsson K; Vivar Pomiano N; Tesi B; Tobiasson M; Creignou M; Ungerstedt J
    Lakartidningen; 2022 Sep; 119():. PubMed ID: 36082915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune manifestations in VEXAS: Opportunities for integration and pitfalls to interpretation.
    Bruno A; Gurnari C; Alexander T; Snowden JA; Greco R;
    J Allergy Clin Immunol; 2023 May; 151(5):1204-1214. PubMed ID: 36948992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.
    Patel N; Dulau-Florea A; Calvo KR
    Semin Hematol; 2021 Oct; 58(4):204-211. PubMed ID: 34802541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
    Beck DB; Bodian DL; Shah V; Mirshahi UL; Kim J; Ding Y; Magaziner SJ; Strande NT; Cantor A; Haley JS; Cook A; Hill W; Schwartz AL; Grayson PC; Ferrada MA; Kastner DL; Carey DJ; Stewart DR
    JAMA; 2023 Jan; 329(4):318-324. PubMed ID: 36692560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS.
    van der Made CI; Potjewijd J; Hoogstins A; Willems HPJ; Kwakernaak AJ; de Sevaux RGL; van Daele PLA; Simons A; Heijstek M; Beck DB; Netea MG; van Paassen P; Elizabeth Hak A; van der Veken LT; van Gijn ME; Hoischen A; van de Veerdonk FL; Leavis HL; Rutgers A
    J Allergy Clin Immunol; 2022 Jan; 149(1):432-439.e4. PubMed ID: 34048852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review.
    Guerrero-Bermúdez CA; Cardona-Cardona AF; Ariza-Parra EJ; Arostegui JI; Mensa-Vilaro A; Yague J; Vásquez G; Muñoz-Vahos CH
    Clin Rheumatol; 2022 Nov; 41(11):3565-3572. PubMed ID: 35986821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series.
    Koster MJ; Kourelis T; Reichard KK; Kermani TA; Beck DB; Cardona DO; Samec MJ; Mangaonkar AA; Begna KH; Hook CC; Oliveira JL; Nasr SH; Tiong BK; Patnaik MM; Burke MM; Michet CJ; Warrington KJ
    Mayo Clin Proc; 2021 Oct; 96(10):2653-2659. PubMed ID: 34489099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case Report: Genetic Double Strike: VEXAS and TET2-Positive Myelodysplastic Syndrome in a Patient With Long-Standing Refractory Autoinflammatory Disease.
    Lötscher F; Seitz L; Simeunovic H; Sarbu AC; Porret NA; Feldmeyer L; Borradori L; Bonadies N; Maurer B
    Front Immunol; 2021; 12():800149. PubMed ID: 35126364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome.
    Stiburkova B; Pavelcova K; Belickova M; Magaziner SJ; Collins JC; Werner A; Beck DB; Balajkova V; Salek C; Vostry M; Mann H; Vencovsky J
    Arthritis Rheumatol; 2023 Jul; 75(7):1285-1290. PubMed ID: 36762418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic manifestations of VEXAS syndrome.
    Groarke EM; Dulau-Florea AE; Kanthi Y
    Semin Hematol; 2021 Oct; 58(4):230-238. PubMed ID: 34802545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Looking beyond VEXAS: Coexistence of undifferentiated systemic autoinflammatory disease and myelodysplastic syndrome.
    Oganesyan A; Hakobyan Y; Terrier B; Georgin-Lavialle S; Mekinian A
    Semin Hematol; 2021 Oct; 58(4):247-253. PubMed ID: 34802547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAK inhibitors for the treatment of VEXAS syndrome.
    Bindoli S; Baggio C; Doria A; Bertoldo E; Sfriso P
    Exp Biol Med (Maywood); 2023 May; 248(5):394-398. PubMed ID: 37243340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEXAS syndrome.
    Nakajima H; Kunimoto H
    Int J Hematol; 2024 May; ():. PubMed ID: 38819628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review.
    Shaukat F; Hart M; Burns T; Bansal P
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):134-139. PubMed ID: 34480172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT.
    Gurnari C; McLornan DP
    Bone Marrow Transplant; 2022 Nov; 57(11):1642-1648. PubMed ID: 35941354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignancies.
    Sakuma M; Blombery P; Meggendorfer M; Haferlach C; Lindauer M; Martens UM; Kern W; Haferlach T; Walter W
    Leukemia; 2023 May; 37(5):1080-1091. PubMed ID: 36823397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEXAS syndrome in dermatology.
    Afsahi V; Christensen RE; Alam M
    Arch Dermatol Res; 2023 Mar; 315(2):161-164. PubMed ID: 35201420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.
    Ferrada MA; Sikora KA; Luo Y; Wells KV; Patel B; Groarke EM; Ospina Cardona D; Rominger E; Hoffmann P; Le MT; Deng Z; Quinn KA; Rose E; Tsai WL; Wigerblad G; Goodspeed W; Jones A; Wilson L; Schnappauf O; Laird RS; Kim J; Allen C; Sirajuddin A; Chen M; Gadina M; Calvo KR; Kaplan MJ; Colbert RA; Aksentijevich I; Young NS; Savic S; Kastner DL; Ombrello AK; Beck DB; Grayson PC
    Arthritis Rheumatol; 2021 Oct; 73(10):1886-1895. PubMed ID: 33779074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.